Quick Summary: Ohio R&D Tax Credit

The Ohio Research and Development (R&D) Investment Tax Credit is a nonrefundable incentive calculated as seven percent of the excess of a taxpayer’s current-year qualified research expenses over their average expenses from the three preceding years. This mechanism serves as a dollar-for-dollar offset against the Ohio Commercial Activity Tax (CAT), specifically rewarding businesses that increase their year-over-year investment in innovation within the state.

The functional application of the seven percent credit percentage is not merely a static reduction of total research costs but rather a sophisticated fiscal lever designed to incentivize growth. By applying the percentage only to the “excess” or incremental spending over a rolling three-year base period, the Ohio General Assembly has ensured that the state’s tax expenditures are directed toward businesses that are actively scaling their technological capabilities. This incremental structure is foundational to understanding the credit’s value proposition: a company that maintains a flat R&D budget receives zero benefit, while a company that doubles its investment receives a substantial subsidy that effectively lowers the net cost of every new research dollar by seven cents. This policy reflects a broader economic strategy within the Midwest to compete for high-wage jobs in engineering, software development, and specialized manufacturing by lowering the tax burden associated with technical experimentation and the elimination of uncertainty.

Historical Context and Legislative Evolution

The architecture of the Ohio R&D tax credit has undergone significant transformations as the state’s broader tax landscape shifted from traditional corporate income taxes to a gross receipts-based system. Originally, the credit was designed to offset the Corporation Franchise Tax, a move that aligned Ohio with federal standards established in 1981. As the state recognized the need for a more stable and predictable revenue stream, the transition to the Commercial Activity Tax (CAT) necessitated a mirroring of these credits to maintain Ohio’s competitive position for R&D-intensive industries.

The legislative journey began in earnest with the enactment of the credit for qualified research expenses in 2005 via House Bill 66, which initially sought to transition the R&D incentive into the newly created CAT framework. This evolution was further refined in 2009 through House Bill 1, which addressed the needs of financial institutions and insurance companies, ensuring they remained eligible for similar incentives under their respective tax regimes. The most recent and impactful changes occurred with the passage of Am. Sub. House Bill 33 in 2023, which codified aggressive audit policies and standardizing record-keeping requirements that had previously existed only in administrative guidance.

Legislative Milestone Effective Date Key Impact on R&D Credit
House Bill 66 July 1, 2005 Established the R&D credit within the Commercial Activity Tax (CAT).
House Bill 1 Oct. 16, 2009 Refined credit availability for financial institutions and insurance groups.
House Bill 197 March 27, 2020 Codified definitions and administrative procedures during the pandemic.
House Bill 33 Jan. 1, 2024 Mandated member-by-member calculation and authorized audit sampling.

This timeline illustrates a deliberate trend toward administrative rigor. While the credit has always been “self-certifying”—meaning no pre-approval is required—the state has increasingly empowered the Department of Taxation to scrutinize the underlying technical data to ensure that “qualified research” meets the stringent definitions found in the federal tax code.

The Statutory Mechanism of the Seven Percent Credit

The primary authority for the 7% credit as applied to most Ohio businesses is found in Ohio Revised Code (ORC) Section 5751.51. The statute provides that for calendar years beginning on or after January 1, 2008, a taxpayer may claim a nonrefundable credit equal to seven percent of the amount by which “qualified research expenses” incurred in Ohio during the calendar year exceed the taxpayer’s average annual qualified research expenses for the three preceding calendar years.

Defining Qualified Research Expenses (QREs)

To ensure consistency and ease of compliance, the Ohio statute adopts the federal definition of “qualified research expenses” found in Section 41 of the Internal Revenue Code (IRC). This “piggyback” approach means that if an expense qualifies for the federal R&D tax credit, it is generally eligible for the Ohio credit, provided the activity occurred within the state.

The expenses typically fall into four distinct silos, which must be documented meticulously to survive a state audit:

  1. Internal Wages: These are the W-2 taxable wages paid to employees for “qualified services.” This includes not only the researchers themselves but also those in direct supervision or direct support roles, such as a lab technician or a manager overseeing a specific scientific project.
  2. Supplies: Tangible property used in the research process, such as prototypes, testing materials, and lab chemicals. Specifically excluded are land and improvements to real property, as well as any property of a character subject to the allowance for depreciation.
  3. Contract Research: Payments to third parties (contractors, universities, or outside labs) for research conducted on the taxpayer’s behalf. Crucially, the law permits only 65% of these expenses to be included in the calculation of the credit base.
  4. Computer Rental and Lease Costs: Expenses for the use of computers in the conduct of qualified research. In the modern era, this increasingly includes cloud-based computing resources and server capacity used for simulations or software testing.

The Nonrefundability and Carryforward Provisions

Because the Ohio R&D credit is nonrefundable, it can reduce a taxpayer’s CAT liability to zero but cannot result in a payment from the state if the credit exceeds the tax due. This characteristic distinguishes it from some of the state’s other incentives, such as the Motion Picture Production Credit, which is fully refundable. To prevent the loss of value for high-innovation companies during years of low revenue, the law allows a seven-year carryforward period.

This carryforward mechanism is vital for the state’s “innovation ecosystem.” It acknowledges that research breakthroughs often take years to commercialize. A biotech startup may spend millions on R&D today without any sales, accumulating credits that will offset their future CAT liability once they achieve market success. Under ORC 5751.51(B)(2), any credit amount in excess of the tax due (after allowing for prior credits) may be carried forward for no more than seven tax years, with the oldest credits applied first.

Local Revenue Office Guidance and the Application of the Law

The Ohio Department of Taxation (ODT) serves as the primary administrative body governing the R&D credit. Through Information Releases and the Ohio Administrative Code (OAC), the ODT provides the granular detail necessary for taxpayers to apply the statutory language to their specific business operations.

Calculation Methodology and the “Base Amount”

The ODT’s guidance, specifically OAC 5703-29-22(C)(3), clarifies that the 7% rate must be applied to the net increase in spending. If a company’s research spending decreases or remains stagnant, no credit is generated for that year. This creates a “rolling base” where each year of high spending increases the hurdle for the following year’s credit, a design that forces companies to either continually increase their R&D budget or wait for the three-year average to reset downward.

The mathematical formula for the credit is expressed as:

$$Credit = 0.07 \times (QRE_{current} – \frac{QRE_{n-1} + QRE_{n-2} + QRE_{n-3}}{3})$$

Where $QRE_{current}$ is the qualifying expenditure in the year of the claim, and the fraction represents the average of the three preceding years. If the taxpayer has no history of R&D in Ohio (e.g., a new business or a company moving its research center to the state), the base amount is treated as zero, allowing the 7% credit to apply to the entire first-year spend.

Member-by-Member Calculation Requirements

One of the most critical nuances in ODT guidance involves how the credit is claimed by affiliated groups. For tax periods beginning on or after January 1, 2024, House Bill 33 mandates that consolidated elected and combined taxpayer groups must calculate the credit on a “member-by-member” basis. This requires each individual entity within the group to track its own Ohio QREs and its own three-year base independently.

This directive prevents “averaging” across a diverse corporate group. For example, if a conglomerate owns a high-growth tech subsidiary and a stagnant manufacturing subsidiary, it cannot aggregate their expenses to create an artificial “growth” narrative for the tech company if the manufacturer’s R&D spend has plummeted. Each entity must demonstrate its own incremental growth to justify its portion of the 7% credit.

Order of Credits and the CAT Hierarchy

The ODT also specifies the “ordering” of credits. Under ORC 5751.98, the R&D credit must be claimed after the nonrefundable Jobs Retention Credit but before the R&D Loan Repayment Credit and any refundable credits. This hierarchy ensures a uniform procedure for calculating tax liability and prevents taxpayers from skipping over nonrefundable credits that have expiration dates.

Credit Order Credit Type Statutory Section
1 Nonrefundable Jobs Retention Credit ORC 5751.50(B)
2 Nonrefundable Credit for Qualified Research Expenses ORC 5751.51(B)
3 Nonrefundable Credit for R&D Loan Payments ORC 5751.52(B)
4 Nonrefundable Credit for Unused Net Operating Losses ORC 5751.53
5 Refundable Motion Picture/Theatrical Credit ORC 5751.54

Quantitative Example: Scaling Innovation in Ohio

To illustrate the financial impact of the 7% credit, consider “Buckeye Advanced Robotics,” an Ohio-based firm that has been steadily increasing its R&D presence. The following scenario demonstrates the transition from a zero-base startup to an established research entity.

Scenario: The Growth Phase (Years 1-4)

In its first three years, the company established its lab and began hiring specialized engineers. In Year 4, it significantly expanded its operations.

Year Ohio QREs 3-Year Base Avg Excess QREs Ohio R&D Credit (7%)
Year 1 $1,000,000 $0 $1,000,000 $70,000
Year 2 $1,200,000 $333,333 $866,667 $60,667
Year 3 $1,500,000 $733,333 $766,667 $53,667
Year 4 $2,400,000 $1,233,333 $1,166,667 $81,667

In this example, the total credit generated over four years is $266,001. If the company’s CAT liability in Year 4 was only $50,000, the firm would pay zero tax and carry forward the remaining $31,667 for use in the following seven years.

Scenario: The Impact of a Spending Plateau

If Buckeye Advanced Robotics maintains its Year 4 spending level of $2,400,000 into Year 5, the incremental nature of the credit will drastically reduce the benefit.

  • Year 5 Spending: $2,400,000
  • New 3-Year Base: ($1,200,000 + $1,500,000 + $2,400,000) / 3 = $1,700,000
  • Excess QREs: $2,400,000 – $1,700,000 = $700,000
  • Year 5 Credit: $700,000 \times 0.07 = $49,000

This demonstrates the “hurdle” effect. Even though the company is still spending the same high amount on research ($2.4 million), its tax benefit drops from $81,667 to $49,000 because its growth relative to its own history has slowed. This causal relationship is intended to discourage corporate “stagnation” and ensures that the 7% rate is always pushing the envelope of new investment.

Audit Risks and Regulatory Compliance Standards

The Ohio Department of Taxation has transitioned into a more aggressive posture regarding the substantiation of R&D credits. While the credit follows federal IRC 41 rules, the ODT has clarified that it will independently verify whether activities meet the “Four-Part Test” rather than simply deferring to the Internal Revenue Service.

The “Four-Part Test” in the Eyes of the ODT

Taxpayers must be prepared to defend their projects against four criteria that distinguish research from routine engineering or production:

  1. Permitted Purpose Test: The research must relate to a new or improved function, performance, reliability, or quality of a business component.
  2. Elimination of Uncertainty Test: The taxpayer must demonstrate that at the outset, they were uncertain about the capability or method of achieving the result, or the final design.
  3. Process of Experimentation Test: This is often the most difficult to prove. It requires evidence of a systematic evaluation of alternatives, such as modeling, simulation, or trial-and-error, as opposed to simply following known industry standard procedures.
  4. Technological in Nature Test: The research must fundamentally rely on the physical or biological sciences, engineering, or computer science.

Audit Sampling and Record Retention

Under HB 33, the Tax Commissioner is explicitly authorized to use a “representative sample” of research projects and expenses to determine the validity of the entire credit. If an auditor finds that 10% of the sampled projects do not meet the Four-Part Test, they may apply that 10% reduction to the entire credit amount claimed for that year.

Taxpayers are required to maintain records for at least four years after the return is filed or the due date of the return, whichever is later. These records must include:

  • Employee Documentation: Time-tracking logs, project notes, and emails linking specific employees to qualified research tasks.
  • Financial Records: Detailed ledgers of supplies used in R&D and clear documentation showing that contract research occurred within Ohio.
  • Federal Alignment: Copies of Federal Form 6765 (Credit for Increasing Research Activities) and any related workpapers.

Economic Impact and Industry-Specific Statistics

The Ohio R&D tax credit is not distributed evenly across the economy. It is heavily concentrated in sectors that require high capital investment and specialized labor. According to state expenditure reports, the manufacturing sector remains the primary driver of these claims, followed closely by agriculture and transportation.

Revenue Foregone and State Investment

Ohio’s biennial budget reports reveal that the state forgoes significant revenue to support these innovation activities. For the 2024-2025 biennium, the “Research and Development Investment Tax Credit” (Item 4.14 in the Expenditure Report) is estimated to result in a revenue loss to the General Revenue Fund (GRF) of approximately $33.1 million in FY 2024 and $34.9 million in FY 2025.

Fiscal Year Estimated Revenue Foregone (Millions)
FY 2022 $28.8
FY 2023 $31.1
FY 2024 $33.1
FY 2025 $34.9

While these figures represent a cost to the state, they are viewed as “innovation capital” that solidifies Ohio’s status as a Midwestern tech hub. For comparison, the state also incentivizes venture capital through a new 100% deduction on capital gains from Ohio-based venture funds starting in 2026, creating a holistic environment where R&D leads to commercialization and subsequent tax-efficient exits.

The CAT Threshold Paradox

A secondary trend emerging from the 2023 budget bill is the increase in the CAT exclusion threshold. Starting in 2024, businesses with less than $3 million in Ohio taxable gross receipts are excluded from the tax entirely; this threshold rises to $6 million in 2025. While this provides massive relief for small businesses, it effectively renders the R&D credit useless for early-stage companies that fall below these sales figures, as they no longer have a CAT liability to offset.

However, for mid-sized and large enterprises—those with receipts well above $6 million—the 7% credit remains a vital strategic asset. These larger firms continue to pay the flat 0.26% CAT rate on receipts above the exclusion amount, and the R&D credit remains the most accessible tool for lowering that effective rate.

Comparative Analysis: R&D Investment Tax Credit vs. R&D Loan Credit

Taxpayers often confuse the 7% R&D Investment Tax Credit (ORC 5751.51) with the Research and Development Investment Loan Credit (ORC 5751.52/166.21). While both are nonrefundable and targeted at innovation, their mechanisms and limitations differ substantially.

The R&D Loan Credit is tied to the JobsOhio program and the Ohio Department of Development. It provides a credit for 100% of the principal and interest payments made on a loan from the Research and Development Investment Loan Fund. Unlike the 7% credit, which is calculated based on “excess” expenses, the loan credit is based on the financing of the R&D project itself.

Feature R&D Investment Tax Credit R&D Investment Loan Credit
Percentage 7% 100% of loan payments
Base Period 3-Year Rolling Average None (Based on loan term)
Max Cap None (Incremental based) Generally $150,000 per year
Prerequisites Conduct “Qualified Research” DSA/JobsOhio Loan Agreement
Application Claim on tax return Certificate from DSA Required

This comparison highlights the state’s bifurcated approach: one credit (the 7%) encourages the operational growth of research departments, while the other (the loan credit) incentivizes the construction of new research facilities and the purchase of high-cost laboratory equipment.

Strategic Implications for Ohio Businesses

The 7% credit rate serves as a signal to the national market that Ohio is “open for innovation.” By maintaining a permanent, nonrefundable credit that aligns with federal definitions, the state offers a predictable fiscal environment that is highly attractive to industries like aerospace, 3D printing, and software engineering.

The Role of Pass-Through Entities (PTEs)

For owners of S-corporations, partnerships, and LLCs, the Ohio R&D credit presents unique opportunities and complexities. While the CAT is an entity-level tax, the R&D credit effectively reduces the tax burden on the business’s Ohio operations, thereby increasing the net income that flows through to the owners. Furthermore, under ORC 5747.331, certain R&D-related credits can flow through directly to an individual’s income tax return if the credit is based on ownership of a PTE that holds the relevant certificate.

The “related member” add-back rules also come into play. Ohio requires PTEs to add back certain expenses paid to owners or family members, but the R&D credit can serve as a countervailing force, reducing the overall tax liability generated by these complex ownership structures.

Manufacturing and the Sales Tax Exemption

It is worth noting that the R&D Investment Tax Credit is often paired with the Ohio Research and Development Sales Tax Exemption. While the 7% credit offsets the CAT (a tax on sales), the sales tax exemption allows businesses to purchase machinery and equipment used primarily for research without paying state or local sales tax. This “double benefit” makes Ohio a premier destination for pilot-scale manufacturing and prototype development, as it lowers both the “front-end” cost of equipment and the “back-end” tax on commercial activity.

Final Thoughts: Navigating the Future of Ohio Innovation

The Ohio Research and Development Investment Tax Credit, with its signature 7% incremental rate, remains one of the most significant and durable business incentives in the state’s tax code. By rewarding growth rather than mere presence, the credit aligns the state’s fiscal interests with the success of its most innovative companies. However, the path to claiming and defending this credit has become increasingly narrow due to legislative updates in House Bill 33 and the evolving interpretation of “qualified research” by the Department of Taxation.

For business leaders and tax practitioners, the 7% credit should be viewed as a long-term strategic tool. It requires a commitment to rigorous documentation, a clear understanding of member-by-member calculation rules for large groups, and a proactive approach to audit readiness. As Ohio’s tech sector continues to mature, and as the CAT exclusion thresholds shift the tax burden onto larger enterprises, the importance of maximizing the R&D credit will only increase. By weaving together federal standards with Ohio-specific administrative guidance, businesses can ensure that their investments in the future are fully supported by the state’s fiscal policy.

Who We Are:

Swanson Reed is one of the largest Specialist R&D Tax Credit advisory firm in the United States. With offices nationwide, we are one of the only firms globally to exclusively provide R&D Tax Credit consulting services to our clients. We have been exclusively providing R&D Tax Credit claim preparation and audit compliance solutions for over 30 years. Swanson Reed hosts daily free webinars and provides free IRS CE and CPE credits for CPAs.

Are you eligible?

R&D Tax Credit Eligibility AI Tool

Why choose us?

R&D tax credit

Pass an Audit?

R&D tax credit

What is the R&D Tax Credit?

The Research & Experimentation Tax Credit (or R&D Tax Credit), is a general business tax credit under Internal Revenue Code section 41 for companies that incur research and development (R&D) costs in the United States. The credits are a tax incentive for performing qualified research in the United States, resulting in a credit to a tax return. For the first three years of R&D claims, 6% of the total qualified research expenses (QRE) form the gross credit. In the 4th year of claims and beyond, a base amount is calculated, and an adjusted expense line is multiplied times 14%. Click here to learn more.

Never miss a deadline again

R&D tax credit

Stay up to date on IRS processes

Discover R&D in your industry

R&D Tax Credit Preparation Services

Swanson Reed is one of the only companies in the United States to exclusively focus on R&D tax credit preparation. Swanson Reed provides state and federal R&D tax credit preparation and audit services to all 50 states.

If you have any questions or need further assistance, please call or email our CEO, Damian Smyth on (800) 986-4725.
Feel free to book a quick teleconference with one of our national R&D tax credit specialists at a time that is convenient for you.

R&D Tax Credit Audit Advisory Services

creditARMOR is a sophisticated R&D tax credit insurance and AI-driven risk management platform. It mitigates audit exposure by covering defense expenses, including CPA, tax attorney, and specialist consultant fees—delivering robust, compliant support for R&D credit claims. Click here for more information about R&D tax credit management and implementation.

Our Fees

Swanson Reed offers R&D tax credit preparation and audit services at our hourly rates of between $195 – $395 per hour. We are also able offer fixed fees and success fees in special circumstances. Learn more at https://www.swansonreed.com/about-us/research-tax-credit-consulting/our-fees/

R&D Tax Credit Training for CPAs

R&D tax credit

Upcoming Webinars

R&D Tax Credit Training for CFPs

bigstock Image of two young businessmen 521093561 300x200

Upcoming Webinars

R&D Tax Credit Training for SMBs

water tech

Upcoming Webinars